Figure 2 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
<p>Use of adjuvant hormone therapy across 10 years in women diagnosed with breast cancer in Stockholm, Sweden, 2005–2020. The dashed vertical lines indicate six months after finishing 5 years of adjuvant hormone therapy—a period that was used to define therapy extension.</p>
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Drugi avtorji: | , , , |
| Izdano: |
2025
|
| Teme: | |
| Oznake: |
Označite
Brez oznak, prvi označite!
|